Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus

References

• Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32(Suppl. 2):64–78
   PubMed Web of Science ®Google Scholar
• Kramer HJ, Nguyen QD, Curhan G, Hsu C. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. J Am Med Assoc. 2003;289:3273–3277
   PubMed Web of Science ®Google Scholar
• MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil KJ, Jerums G. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care. 2004;27:195–200
   PubMed Web of Science ®Google Scholar
• Rigalleau V, Lasseur C, Raffaitin C, et al. Normoalbuminuric renal-insufficient diabetic patients. Diabetes Care. 2007;30:2034–2039
   PubMed Web of Science ®Google Scholar
• Thomas MC, MacIsaac RJ, Jerums G, et al. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (National Evaluation of the Frequency of Renal Impairment cOexisting with NIDDM [NEFRON] 11). Diabetes Care. 2009;32:1497–1502
   Google Scholar
• Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M, and on behalf of Japan Diabetes Clinical Data Management Study Group. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant. 2009;24:1212–1219
   Google Scholar
• Penno G, Solini A, Bonora E, et al. Renal insufficiency and cardiovascular events (RIACE) study group. J Hypertens. 2011;29:1802–1809
   PubMed Web of Science ®Google Scholar
• Dwyer JP, Parving HH, Hunsicker LG, Ravid M, Remuzzi G, Lewis JB, for the DEMAND Investigators. Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND Study. Cardiorenal Med. 2012;2:1–10
   Google Scholar
• Afghahi H, Miftaraj M, Svensson AM, et al. Swedish National Diabetes Register (NDR). Ongoing treatment with renin--angiotensin--aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population. J Diabetes Complications. 2013;27:229–234
   Google Scholar
• Mottl AK, Kwon KS, Mauer M, Mayer-Davis EJ, Hogan SL, Kshirsagar AV. Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications. 2013;27:123–127
   PubMed Web of Science ®Google Scholar
• De Zeeuw D, Remuzzi G, Parving H-H, et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int. 2004;65:2309–2320
   PubMed Web of Science ®Google Scholar
• Lorenzo V, Boronat M, Saavedra P, et al. Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk. Nephrol Dial Transplant. 2010;25:2283–2288
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Available at: http://www.kidney.org/professionals/kdoqi/guidelines_ckd/toc.htm. Accessed May 20, 2013
   Google Scholar
• Instituto Nacional de Estadística (Statistics National Institute). Encuesta Nacional de Salud. Cuestionario de adultos (personas de 16 y más años). Available at: http://www.ine.es/metodologia/t15/ens_adu06.pdf. Accessed May 20, 2013
   Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
   PubMed Web of Science ®Google Scholar
• Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, for the UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes. U.K. Prospective Diabetes Study 74. Diabetes. 2006;55:1832–1839
   PubMed Web of Science ®Google Scholar
• Araki S, Haneda M, Sugimoto T, et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54:2983–2987
   PubMed Web of Science ®Google Scholar
• Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P, for the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345:870–878
   PubMed Web of Science ®Google Scholar
• Afghahi H, Cederholm J, Eliasson B, et al. MK. Risk factors for the development of albuminuria and renal impairment in type 2 diabetes. The Swedish National Diabetes Register (NDR). Nephrol Dial Transplant. 2011;26:1236–1243
   Google Scholar
• Cirillo M, Anastasio P, De Santo NG. Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant. 2005;20:1791–1798
   PubMed Web of Science ®Google Scholar
• Christensen PK, Larsen S, Horn T, Olsen S, Parving HH. Renal function and structure in albuminuric type 2 diabetic patients without retinopathy. Nephrol Dial Transplant. 2001;16:2337–2347
   PubMed Web of Science ®Google Scholar
• Harada K, Akai Y, Sumida K, et al. Significance of renal biopsy in patients with presumed diabetic nephropathy. J Diabetes Invest. 2013;4:88–93
   Google Scholar
• Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care. 1996;19:1243–1248
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ III, O’Brien PC. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care. 1999;22:1479–1486
   PubMed Web of Science ®Google Scholar